Filing Details
- Accession Number:
- 0001209191-16-156269
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-21 11:54:58
- Reporting Period:
- 2016-12-19
- Filing Date:
- 2016-12-21
- Accepted Time:
- 2016-12-21 11:54:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238362 | John Mendlein | 3545 John Hopkins Court, Suite 250 San Diego CA 92121 | Ceo And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-19 | 69,000 | $2.20 | 324,971 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average price for the shares. The shares were purchased at prices ranging from $2.125 to $2.25 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Includes 2,500 shares acquired under the Company's 2015 Employee Stock Purchase Plan ("ESPP") on May 15, 2016 and 2,500 shares acquired under the ESPP on November 15, 2016.
Billionaire Hedge Funds
